BioGenerator Ventures


BioGenerator Ventures creates, builds, and invests in early-stage companies addressing human health and agriculture. It provides staged, catalytic capital from an evergreen fund model and pairs investment with a company-building engine (BioGenerator Labs) that offers lab space, coaching, grant support, talent, and investor relations to de-risk and scale ventures.

Industries

biotechnology
finance
venture-capital-b37d

Nr. of Employees

small (1-50)

BioGenerator Ventures


Portfolio

Published pivotal trial results; BioGenerator led an independent diligence process that catalyzed Series B.

#Diagnostics / Human health

Commercial partnership valuing the company at over $400M; later FDA approval of transdermal GFR system noted in site news.

#Medical devices / Diagnostics

Successful exit for investors following Bayer's control acquisition.

#Agriculture / Agtech

Acquired by Lightbeam Health Solutions.

#Healthcare / Digital health

Raised $172M to advance NK cell platform and programs.

#Therapeutics / Cell therapy

Went public in a $2 billion SPAC merger; BioGenerator led initial financing.

#Agtech / Food tech

View All Portfolio Items

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.